Treace Medical Concepts (TMCI) Receivables - Net (2020 - 2026)
Treace Medical Concepts filings provide 6 years of Receivables - Net readings, the most recent being $42.2 million for Q4 2025.
- On a quarterly basis, Receivables - Net rose 3.42% to $42.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $42.2 million, a 3.42% increase, with the full-year FY2025 number at $42.2 million, up 3.42% from a year prior.
- Receivables - Net hit $42.2 million in Q4 2025 for Treace Medical Concepts, up from $33.0 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $42.2 million in Q4 2025 to a low of $10.0 million in Q2 2021.
- Median Receivables - Net over the past 5 years was $25.5 million (2023), compared with a mean of $25.2 million.
- Biggest five-year swings in Receivables - Net: skyrocketed 65.03% in 2023 and later decreased 6.14% in 2024.
- Treace Medical Concepts' Receivables - Net stood at $18.6 million in 2021, then soared by 57.24% to $29.2 million in 2022, then skyrocketed by 30.5% to $38.1 million in 2023, then increased by 7.09% to $40.8 million in 2024, then rose by 3.42% to $42.2 million in 2025.
- The last three reported values for Receivables - Net were $42.2 million (Q4 2025), $33.0 million (Q3 2025), and $30.3 million (Q2 2025) per Business Quant data.